N,N-dimethyl-4-[5-[2-[(1-methylpiperidin-4-yl)methyl]indazol-5-yl]-1H-pyrrolo[2,3-b]pyridin-3-yl]benzamide
C30H32N6O — CID 156778038
Data last refreshed: (MolForge compound catalog, from PubChem)
About N,N-dimethyl-4-[5-[2-[(1-methylpiperidin-4-yl)methyl]indazol-5-yl]-1H-pyrrolo[2,3-b]pyridin-3-yl]benzamide
N,N-dimethyl-4-[5-[2-[(1-methylpiperidin-4-yl)methyl]indazol-5-yl]-1H-pyrrolo[2,3-b]pyridin-3-yl]benzamide (PubChem CID 156778038) has the molecular formula C30H32N6O and a molecular weight of 492.63 g/mol. Its IUPAC name is N,N-dimethyl-4-[5-[2-[(1-methylpiperidin-4-yl)methyl]indazol-5-yl]-1H-pyrrolo[2,3-b]pyridin-3-yl]benzamide.
Molecular Properties
| Compound Name | N,N-dimethyl-4-[5-[2-[(1-methylpiperidin-4-yl)methyl]indazol-5-yl]-1H-pyrrolo[2,3-b]pyridin-3-yl]benzamide |
|---|---|
| PubChem CID | 156778038 |
| Molecular Formula | C30H32N6O |
| Molecular Weight | 492.63 g/mol |
| Exact Mass | 492.26 |
| IUPAC Name | N,N-dimethyl-4-[5-[2-[(1-methylpiperidin-4-yl)methyl]indazol-5-yl]-1H-pyrrolo[2,3-b]pyridin-3-yl]benzamide |
| SMILES | CN1CCC(Cn2cc3cc(-c4cnc5[nH]cc(-c6ccc(C(=O)N(C)C)cc6)c5c4)ccc3n2)CC1 |
| InChI | InChI=1S/C30H32N6O/c1-34(2)30(37)22-6-4-21(5-7-22)27-17-32-29-26(27)15-24(16-31-29)23-8-9-28-25(14-23)19-36(33-28)18-20-10-12-35(3)13-11-20/h4-9,14-17,19-20H,10-13,18H2,1-3H3,(H,31,32) |
| InChIKey | RFSQAEBGLHJVKB-UHFFFAOYSA-N |
| XLogP | 5.29 |
| TPSA | 70.05 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 37 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 492.63 |
| LogP ≤ 5 | 5.29 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 156778038 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.